Home Cart Sign in  
Chemical Structure| 1884712-47-3 Chemical Structure| 1884712-47-3
Chemical Structure| 1884712-47-3

CPI-637

CAS No.: 1884712-47-3

CPI-637 is an efficient inhibitor of CBP/EP300 bromodomain with IC50 of 0.03 ± 0.01μM.

4.5 *For Research Use Only !

Cat. No.: A788310 Purity: 98+%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇď¶ÊÊ Inquiry Inquiry
5mg ł§ÿ¶ÊÊ Inquiry Inquiry
10mg łÍó¶ÊÊ Inquiry Inquiry
50mg łÇ§ò¶ÊÊ Inquiry Inquiry
100mg łË§§¶ÊÊ Inquiry Inquiry
250mg ł§îÿ¶ÊÊ Inquiry Inquiry
1g łÇÍÇò¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÇď¶ÊÊ

  • 5mg

    ł§ÿ¶ÊÊ

  • 10mg

    łÍó¶ÊÊ

  • 50mg

    łÇ§ò¶ÊÊ

  • 100mg

    łË§§¶ÊÊ

  • 250mg

    ł§îÿ¶ÊÊ

  • 1g

    łÇÍÇò¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of CPI-637

CAS No. :1884712-47-3
Formula : C22H22N6O
M.W : 386.45
SMILES Code : O=C1C[C@@H](C)NC2=C(C3=CC4=C(N(C)N=C4C5=CN(C)N=C5)C=C3)C=CC=C2N1
MDL No. :MFCD30489741
InChI Key :BFTKDWYIRJGJCA-CYBMUJFWSA-N
Pubchem ID :121271792

Safety of CPI-637

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CPI-637

epigenetics

Isoform Comparison

Biological Activity

Target
  • p300/CBP

    EP300, IC50:0.051 μM

    CBP, IC50:0.03 μM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HL cell lines (L1236, KMH2) 10μM 24 h To evaluate the effect of CPI-637 on HL cell proliferation and CD30 surface expression. Results showed that CPI-637 significantly inhibited cell proliferation and reduced CD30 expression. PMC9949602
ALCL cell lines (DEL, Karpas299, MAC1) 10μM 24 h To evaluate the effect of CPI-637 on ALCL and HL cell proliferation and CD30 surface expression. Results showed that CPI-637 significantly inhibited cell proliferation and reduced CD30 expression. PMC9949602
TZM-bl cells 20 µM 48 h CPI-637 increased LTR-driven luciferase activity, indicating its ability to activate HIV-1 transcription PMC8326664
ACH2 cells 20 µM 48 h CPI-637 significantly increased the expression of HIV-1 p24 antigen, indicating its ability to reverse HIV-1 latent infection PMC8326664
J-Lat 10.6 cells 20 µM 48 h CPI-637 significantly increased the percentage of GFP-positive cells, indicating its ability to reverse HIV-1 latent infection PMC8326664
J-Lat A2 cells 20 µM 48 h CPI-637 significantly increased the percentage of GFP-positive cells, indicating its ability to reverse HIV-1 latent infection PMC8326664

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
NSG mice ALCL and HL xenograft models Oral 50 mg/kg Daily administration until the endpoint To evaluate the effect of CPI-637 on tumor growth in ALCL and HL xenograft models. Results showed that CPI-637 significantly slowed tumor growth and reduced the expression of MYC, IRF4, BATF3, and IL10. PMC9949602

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.94mL

2.59mL

1.29mL

25.88mL

5.18mL

2.59mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories